These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage. Sisakhtpour B; Mirzaei A; Karbasizadeh V; Hosseini N; Shabani M; Moghim S Ann Clin Microbiol Antimicrob; 2022 Jan; 21(1):1. PubMed ID: 34996464 [TBL] [Abstract][Full Text] [Related]
25. Sequential treatment effects on phage-antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii. Mukhopadhyay S; Zhang P; To KKW; Liu Y; Bai C; Leung SSY Int J Antimicrob Agents; 2023 Nov; 62(5):106951. PubMed ID: 37574030 [TBL] [Abstract][Full Text] [Related]
26. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt. Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450 [TBL] [Abstract][Full Text] [Related]
27. Zinc oxide nanoparticles impact the expression of the genes involved in toxin-antitoxin systems in multidrug-resistant Acinetobacter baumannii. Shahbazi S; Shivaee A; Nasiri M; Mirshekar M; Sabzi S; Sariani OK J Basic Microbiol; 2023 Sep; 63(9):1007-1015. PubMed ID: 36086811 [TBL] [Abstract][Full Text] [Related]
29. Comparative transcriptomics of multidrug-resistant Acinetobacter baumannii in response to antibiotic treatments. Qin H; Lo NW; Loo J; Lin X; Yim AK; Tsui SK; Lau TC; Ip M; Chan TF Sci Rep; 2018 Feb; 8(1):3515. PubMed ID: 29476162 [TBL] [Abstract][Full Text] [Related]
30. [Inventory building of phages against extensively drug-resistant Acinetobacter baumannii isolated from wounds of patients with severe burn and related characteristic analysis]. Yang ZC; Deng LY; Gong YL; Yin SP; Jiang B; Huang GT; Peng YZ; Hu FQ Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):517-22. PubMed ID: 27647066 [TBL] [Abstract][Full Text] [Related]
31. Characterization of Virulent T4-Like Peters DL; Davis CM; Harris G; Zhou H; Rather PN; Hrapovic S; Lam E; Dennis JJ; Chen W Viruses; 2023 Mar; 15(3):. PubMed ID: 36992448 [TBL] [Abstract][Full Text] [Related]
32. Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii. Bagińska N; Pichlak A; Górski A; Jończyk-Matysiak E Virol Sin; 2019 Aug; 34(4):347-357. PubMed ID: 31093881 [TBL] [Abstract][Full Text] [Related]
33. Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates. Peng F; Mi Z; Huang Y; Yuan X; Niu W; Wang Y; Hua Y; Fan H; Bai C; Tong Y BMC Microbiol; 2014 Jul; 14():181. PubMed ID: 24996449 [TBL] [Abstract][Full Text] [Related]
34. Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Blasco L; Ambroa A; Lopez M; Fernandez-Garcia L; Bleriot I; Trastoy R; Ramos-Vivas J; Coenye T; Fernandez-Cuenca F; Vila J; Martinez-Martinez L; Rodriguez-Baño J; Pascual A; Cisneros JM; Pachon J; Bou G; Tomas M Microorganisms; 2019 Nov; 7(11):. PubMed ID: 31726694 [TBL] [Abstract][Full Text] [Related]
35. Genomic and phenotypic analyses of multidrug-resistant Kim M; Park J; Park W Virulence; 2021 Dec; 12(1):150-164. PubMed ID: 33372826 [TBL] [Abstract][Full Text] [Related]
36. Synergy of a virulent phage (φAB182) with antibiotics leading to successful elimination of biofilms formed by MDR Vashisth M; Yashveer S; Jaglan AB; Virmani N; Bera BC; Vaid RK; Anand T Can J Microbiol; 2022 Dec; 68(12):731-746. PubMed ID: 36174234 [TBL] [Abstract][Full Text] [Related]
37. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H; Kus H; Arslan U; Tuncer I Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268 [TBL] [Abstract][Full Text] [Related]
38. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647 [TBL] [Abstract][Full Text] [Related]
39. Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant Rathor N; Bahadur T; Thakur CK; Bamola VD; Das BK; Chaudhry R Indian J Med Res; 2023 Jun; 157(6):549-558. PubMed ID: 37530310 [TBL] [Abstract][Full Text] [Related]
40. [Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains]. Yıldırım MI; Tuğrul HM Mikrobiyol Bul; 2011 Jul; 45(3):422-9. PubMed ID: 21935775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]